Zobrazeno 1 - 10
of 21
pro vyhledávání: '"M Ferrit-Martin"'
Publikováno v:
Clinical pharmacy.
Publikováno v:
European Journal of Hospital Pharmacy. 23:A248.3-A249
Background Deviation from the desired beneficial effects of medicines causes drug related problems (DRP). DRP are the cause of morbidity and mortality associated with medicines, and strategies are required to carry out an appropriate approach to this
Autor:
M Rodríguez Goicoechea, MA Calleja Hernández, L Gutiérrez Zúñiga, Caparrós Romero, M Ferrit Martin
Publikováno v:
European Journal of Hospital Pharmacy. 23:A78.3-A79
Background The safety of biologic agents for the treatment of psoriasis has been studied in long term clinical trials with up to 5 years of follow-up. However, observational studies provide the potential to identify safety signals in a real world set
Autor:
MC Sánchez Argaiz, E Espínola García, MA Calleja Hernández, M Ferrit Martin, MC Pérez Pinilla
Publikováno v:
European Journal of Hospital Pharmacy. 23:A228.2-A229
Background One of the main causes of injuries and hospital admissions in older people is falls. The risk of falling can be increased by factors such as vision and balance problems, dementia and drug consumption. In 2012, pharmacists in primary care p
Autor:
MA Calleja Hernández, L Gutiérrez Zúñiga, Caparrós Romero, M Rodríguez Goicoechea, M Ferrit Martin
Publikováno v:
European Journal of Hospital Pharmacy. 23:A76.1-A76
Background Administration of cytokines, such as interleukin 2 and interferon α, has been clinically proven since the 1980s, but today their use in clinical practice has decreased considerably due to the effectiveness of new target treatments, such a
Autor:
M Carrasco Gomariz, SI Garcia Dominguez, A Jiménez Morales, MA Calleja Hernández, M Ferrit Martin, T Simon Sanchez
Publikováno v:
European Journal of Hospital Pharmacy. 23:A110.1-A110
Background The process of distributing drugs to hospitalised patients is complex, which is why it is necessary to establish improvement strategies in hospitals to ensure patient safety, monitoring every point in the process of the distribution of dru
Autor:
M Carrasco Gomariz, F Ibañez Lopez, M Ferrit Martin, N Albina Olalla, MA Calleja Hernández, L Gutiérrez Zúñiga, Caparrós Romero
Publikováno v:
European Journal of Hospital Pharmacy. 23:A134.2-A135
Background The effectiveness and safety of drugs for the treatment of inflammatory rheumatic diseases (IRD) are well known. Patients treated with disease modifying antirheumatic drugs (DMARDs) and anti-tumour necrosis factor alpha (TNF-alpha) drugs d
Autor:
Miguel Ángel Calleja-Hernández, M Carrasco-Gomariz, C Valencia-Soto, F Artime-Rodriguez-Hermida, M Ferrit-Martin, N Martinez-Casanova
Publikováno v:
European Journal of Hospital Pharmacy. 23:A86.1-A86
Background Biological agents are used to treat rheumatic diseases. Patients are initially treated at the recommended dose according to the results of clinical trials but there is no current consensus on what attitude to take following remission. The
Autor:
T Simon Sanchez, MA Calleja Hernández, JE Micó González, M Ferrit Martin, A Jiménez Morales, SE De Jesús, M Rodríguez Goicoechea
Publikováno v:
European Journal of Hospital Pharmacy. 23:A165.2-A165
Background Medical gases (MG) have traditionally been managed by maintenance units. With the new legislation, this management has been taken over by the pharmacy departments. Purpose To measure the economic impact and describe the efficiency measures
Autor:
F Orantes Casado de Amezua, M Lafuente Gonzalez, M Ferrit Martin, MA Calleja Hernández, M Zuzuarregui Girones
Publikováno v:
European Journal of Hospital Pharmacy. 22:A163.3-A164
Background Prescribing potentially inappropriate medications (PIMs) and omitting essential drugs are a common problem in elderly. Application of Beers criteria and screening tool of older persons’ potentially inappropriate prescriptions (STOPP) in